Theravance (THRX), Glaxo (GSK) Report Launch of ANORO ELLIPTA in Japan
Tweet Send to a Friend
On September 4, 2014, GlaxoSmithKline plc (NYSE: GSK) and Theravance, Inc. (Nasdaq: THRX) announced GSK Japan launched ANORO ELLIPTA (umeclidinium/vilanterol) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
